Samuel Bates Martin Celldex Therapeutics, Inc. (CLDX) insider trading activity
Samuel Bates Martin is SVP AND CFO of Celldex Therapeutics, Inc.. Currently has a direct ownership of 28,125 shares of CLDX, which is worth approximately $742,500. The most recent transaction as insider was on Jun 14, 2024, when has been sold 17,172 shares (Common Stock) at a price of $35.42 per share, resulting in proceeds of $608,232. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
28.1K
0%
3M change
15.37%
12M change
Total Value Held
$742,500
Samuel Bates Martin Transaction History
SBM
Samuel Bates Martin
SVP AND CFO
Hampton, NJ